HSPA5 and COVID-19: A recent work studying inflammation and ERS among COVID-19 patients suggested that any SARS-CoV-2 positive patient who showed a GRP78 plasma level superior to 300 pg./mL in serum at the beginning of the infection had a 100% probability of developing pneumonia (15).